Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Croda International ( (GB:CRDA) ) just unveiled an update.
Croda International Plc announced the purchase of shares under the Company’s Share Incentive Plan by Equiniti Share Plan Trustees Limited, involving key managerial personnel. This transaction reflects the company’s commitment to aligning the interests of its executives with those of its shareholders, potentially enhancing stakeholder confidence and supporting its strategic objectives.
The most recent analyst rating on (GB:CRDA) stock is a Hold with a £2914.00 price target. To see the full list of analyst forecasts on Croda International stock, see the GB:CRDA Stock Forecast page.
Spark’s Take on GB:CRDA Stock
According to Spark, TipRanks’ AI Analyst, GB:CRDA is a Neutral.
Croda International’s overall stock score reflects a mix of solid financial health and strategic initiatives, tempered by valuation concerns and technical weaknesses. The company’s strong earnings call and positive corporate events provide a supportive backdrop, but investors should be cautious of the high P/E ratio and bearish technical indicators.
To see Spark’s full report on GB:CRDA stock, click here.
More about Croda International
Croda International Plc operates in the specialty chemicals industry, focusing on the production and distribution of high-performance ingredients and technologies. The company is known for its innovative solutions across various sectors, including personal care, life sciences, and performance technologies.
Average Trading Volume: 732,647
Technical Sentiment Signal: Strong Sell
Current Market Cap: £3.75B
See more insights into CRDA stock on TipRanks’ Stock Analysis page.